There are different modalities of intercellular communication governed by cellular
homeostasis. In this review, we will explore one of these forms of communication called
extracellular vesicles (EVs). These vesicles are released by all cells in the body and are
heterogeneous in nature. The primary function of EVs is to share information through their
cargo consisting of proteins, lipids and nucleic acids (mRNA, miRNA, dsDNA etc.) with
other cells, which have a direct consequence on their microenvironment. We will focus on
the role of EVs of mesenchymal stem cells (MSCs) in the nervous system and how these
participate in intercellular communication to maintain physiological function and provide
neuroprotection. However, deregulation of this same communication system could play a role
in several neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease,
Amyotrophic lateral sclerosis, multiple sclerosis, prion disease and Huntington’s disease.
The release of EVs from a cell provides crucial information to what is happening inside the
cell and thus could be used in diagnostics and therapy. We will discuss and explore new
avenues for the clinical applications of using engineered MSC-EVs and their potential
therapeutic benefit in treating neurodegenerative diseases.